Trial intelligence / Profile preview

Shuxuening Injection for Acute Ischemic Stroke

NCT04950790Phase 4Unknown

Sponsor
Peking University Third Hospital
Start
Apr 2018
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ginkgo biloba leaf extract injection in ischemic stroke, sponsored by Peking University Third Hospital. Status: unknown.

02

Drugs

ginkgo biloba leaf extract injection
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT04950790.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04950790.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call